{
    "2019-10-25": [
        [
            {
                "time": "",
                "original_text": "民生医药|季报点评】天坛生物：收入端保持快速增长, 存货周转加快，景气度持续提升",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "收入端",
                        "快速增长",
                        "存货周转",
                        "景气度"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国信医药】天坛生物：业绩符合预期，预计全年稳健增长（三季报点评）",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "业绩",
                        "符合预期",
                        "稳健增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "天坛生物2019Q3点评:基本符合预期,业绩稳健增长",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "2019Q3",
                        "符合预期",
                        "业绩",
                        "稳健增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "天坛生物:绩整体符合预期,血制品销售逐季增长",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "业绩",
                        "符合预期",
                        "血制品",
                        "销售",
                        "逐季增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}